ML-1 - PDFSEARCH.IO - Document Search Engine

ML-1
Results: 854

#	Item
441	Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Diols Fingolimod Natalizumab Alemtuzumab Immune system Immunosuppressants Immunology Multiple sclerosis
442	6.3 CERTOLIZUMAB PEGOL 200 mg/mL injection, 2 x 1 mL syringes; Cimzia®; UCB Australia Pty Ltd. Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Immunosuppressants Monoclonal antibodies Centocor Arthritis Autoimmune diseases Infliximab Etanercept Psoriatic arthritis Adalimumab Medicine Health Pharmacology
443	14.3 MINOR LISTINGS AND CHANGES TO LISTINGS PROCESSED BY THE SECRETARIAT APOMORPHINE HYDROCHLORIDE Injection, 10 mg in 1 mL, Apomine®, Hospira Pty Ltd Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Catechols Sexual orientation and medicine Midwifery Nurse practitioner Optometry Health care provider Medicine Health Apomorphine
444	Public Summary Document – November 2014 PBAC Meeting 5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Rare diseases Rheumatology Immunosuppressants Anakinra Arthritis Cryopyrin-associated periodic syndrome Familial cold urticaria Muckle–Wells syndrome Neonatal onset multisystem inflammatory disease Health Autoinflammatory syndromes Medicine
445	Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular edema Central retinal vein occlusion Macular degeneration Diabetic retinopathy Macula of retina Central retinal vein Ophthalmology Medicine Health
446	Public Summary Document – November 2014 PBAC Meeting 6.3 CERTOLIZUMAB PEGOL 200 mg/mL injection, 2 x 1 mL syringes; Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Immunosuppressants Monoclonal antibodies Centocor Arthritis Autoimmune diseases Infliximab Psoriatic arthritis Adalimumab Etanercept Medicine Health Pharmacology
447	7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Bevacizumab Vascular endothelial growth factor Macular degeneration Macular edema Pharmaceutical Benefits Scheme Central retinal vein occlusion Off-label use Macula of retina Medicine Ophthalmology Health
448	Public Summary Document – November 2014 PBAC MeetingMINOR LISTINGS AND CHANGES TO LISTINGS PROCESSED BY THE SECRETARIAT APOMORPHINE HYDROCHLORIDE Injection, 10 mg in 1 mL, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Catechols Sexual orientation and medicine Midwifery Nurse practitioner Health care provider Medicine Health Apomorphine
449	6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&) inert substance diluent [1 x 2 ml syringe], 1 pack; Lucrin Depot Paediatric®; AbbVie Pty Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:15 GnRH agonists Leuprorelin Pharmacology Precocious puberty Histrelin Clinical trial Puberty Gonadotropin-releasing hormone Degarelix Medicine Biology Health
450	Public Summary Document – November 2014 PBAC MeetingMERCAPTOPURINE oral suspension 20 mg/mL, 100 mL; Allmercap®; Link Healthcare Pty Ltd. 1 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:15 Chemistry Purines Mercaptopurine Acute lymphoblastic leukemia Tablet Leukemia Dosage forms Pharmacology Pharmaceutical sciences

UPDATE